Athlete group launches platform for investing in minority businesses
Former Pacers big man Antonio Davis is among a cohort of athletes behind an investing platform that targets investments in minority-owned supplier companies.
Former Pacers big man Antonio Davis is among a cohort of athletes behind an investing platform that targets investments in minority-owned supplier companies.
Harry Zhang pleaded guilty to two felonies this month after charged with illegally obtaining prescriptions from Canada and Germany and reselling them in China.
Central Indiana is facing crunch time in its push to bid for the Amazon HQ2 project, with pitches to the Seattle-based company due Oct. 19, less than two weeks away.
Encouraging business investment and accelerating economic growth are always winning strategies. Additional elements of the administration’s proposal bring more benefits for all Hoosier taxpayers.
The U.S. Food and Drug Administration is opening a new front in its efforts to reduce high drug prices by encouraging development of generic versions of hard-to-make medicines.
Thermalin Inc., a Cleveland-based biotech startup that just won $17.5 million in venture capital to develop new insulin therapies, plans to add several researchers to a lab at the Indiana University School of Medicine.
The appointments mark the latest changes in the Indianapolis-based drugmaker’s executive suite since David Ricks took over as CEO in January.
U.S. regulators have approved a new medicine for treating a common type of breast cancer after it has spread to other parts of the body.
Cathy Ferree is trying to usher in an era of change for the Indiana State Museum that will include new permanent exhibits, increased marketing and perhaps most importantly, new programming at the museum meant to increase attendance through repeat visitors.
The National Business Group on Health is projecting the total cost of providing medical and pharmacy benefits to increase 5 percent for the fifth consecutive year in 2018.
The largest individual gift in the theater’s history will be used to create the James Still Playwright-in-Residence Fund.
The residential redevelopment of the sprawling Simon estate on Ditch Road known as Asherwood that local homebuilder Paul Estridge Jr. announced late last year might not happen after all.
The local philanthropic foundation announced Wednesday that the funds would support the American Red Cross, Salvation Army, United Way Worldwide and United Way of Greater Houston.
The Greenfield-based unit, which makes a vast array of vaccines, antibiotics, feed additives and other health products for livestock and pets, is in a slump, after more than a decade of growth.
li Lilly and Co.’s experimental breast cancer drug abemaciclib, when combined with standard therapy, slowed the progression of tumors in patients with an advanced form of the disease.
Tech leaders, including Salesforce CEO Marc Benioff, think Indianapolis would be a great location for Amazon’s second headquarters. And, like other cities in the running, it has some strengths and weaknesses.
Indianapolis-based pharmaceutical giant Eli Lilly and Co. said the 3,500 jobs represent 8.3 percent of its global workforce. Lilly hopes the cuts will save it $500 million a year.
The Paris flights, announced Wednesday, may lessen the urgency local officials feel to attract a direct flight from Indianapolis to London. Delta Air Lines stands to land $5.5 million in incentives if it can keep the flights filled.
Danish drugmaker Novo Nordisk says it has reached a settlement over allegations that it hadn’t properly communicated safety information when marketing a medicine to treat type 2 diabetes.
David Broecker was founding CEO of the four-year-old Indiana Biosciences Research Institute, which aims to bridge the gap between research universities and industry in life sciences.